Lixisenatide Cuts Kidney Damage in T2DM and Coronary Syndrome
Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria
Best Practices for Congenital Adrenal Hyperplasia Updated
Recommendations address screening, treatment approaches and emphasize shared decision making
Industry-Funded Trials Often Involve Employees in Studies
Many trials published in high-impact journals involve funder, academic author in study design, reporting
Albiglutide Beats Placebo for Cardiovascular Events in T2DM
Despite having been withdrawn, albiglutide is superior to placebo for reducing cardiovascular events
Tips Provided for Budgeting in Medical Residency
Medical residents should understand their income, create a budget and stick to it, save for the future
Three-Quarters of Health Care Workers Got Flu Shot Last Year
Lowest rates seen among health workers in long-term care settings
Price Hikes Noted in Small Subset of Generic Drugs
Small but growing proportion of drugs experiencing at least doubling in price
Uninsured Rate at 8.8 Percent in First Quarter of 2018
Rate remained steady compared with 2017 but was substantially lower than rate of 16 percent in 2010
High HbA1c After T1DM Diagnosis Predicts Psychiatric Comorbidity
High HbA1c levels within two years of diagnosis predict increased risk for psychiatric diagnoses
Better Glycemic Control With Closed-Loop Insulin Delivery
Better glycemic control, reduced hypoglycemia risk for T1DM patients with suboptimal glycemic control
